Hcw biologics to participate in h.c. wainwright annual global life sciences conference may 23 – 25, 2022

Miramar, fla., may 23, 2022 (globe newswire) -- hcw biologics inc. (the “company”) (nasdaq: hcwb), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation and age-related diseases, announced today that hing c. wong, ph.d., founder and ceo of hcw biologics, will give a corporate presentation on may 25, 2022 at the h.c. wainwright annual global life sciences conference.
HCWB Ratings Summary
HCWB Quant Ranking